Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008.

October
SunMonTueWedThuFriSat
2829301234567891011121314151617181920212223242526272829303112345678
October
SunMonTueWedThuFriSat
2829301234567891011121314151617181920212223242526272829303112345678
Copyright © Ark Medical Solutions Inc. All Rights Reserved.